PTGDR and neoplasm: Only one fusion was found in more than 1% of tumor or normal cells: NUTM2A-AS1::RP11-203L2.4; notably, fusion gene partner NUTM2A-AS1 has recently been identified as an oncogene with roles in multiple cancer types (Wang et al. 2020, 2021a; Long et al. 2023).